Cargando…
Lipid Abnormalities and Cardiometabolic Risk in Patients with Overt and Subclinical Thyroid Disease
Dyslipidemia is a common finding in patients with thyroid disease, explained by the adverse effects of thyroid hormones in almost all steps of lipid metabolism. Not only overt but also subclinical hypo- and hyperthyroidism, through different mechanisms, are associated with lipid alterations, mainly...
Autores principales: | Peppa, Melpomeni, Betsi, Grigoria, Dimitriadis, George |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140027/ https://www.ncbi.nlm.nih.gov/pubmed/21789282 http://dx.doi.org/10.1155/2011/575840 |
Ejemplares similares
-
Cardiovascular effects of overt and subclinical hyperthyroidism: focus on differentiated thyroid cancer
por: Links, Thera P, et al.
Publicado: (2020) -
Hemostasis in Overt and Subclinical Hyperthyroidism
por: Ordookhani, Arash, et al.
Publicado: (2017) -
Primary mucosa-associated lymphoid tissue thyroid lymphoma: a rare thyroid neoplasm of extrathyroid origin
por: Peppa, Melpomeni, et al.
Publicado: (2012) -
Pituitary Tumorigenesis—Implications for Management
por: Vamvoukaki, Rodanthi, et al.
Publicado: (2023) -
A modern web-based health promotion program for patients in Greece with diabetes 2 and obesity: an interventional study
por: Chrysi, Maria S., et al.
Publicado: (2023)